ROCKET PHARMACEUTICALS INC
RCKT·77313F106·US·Common Stock·Healthcare - Biotechnology-13D/G
RCKT (ROCKET PHARMACEUTICALS INC) is held by 111 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($63.3M), BlackRock, Inc. ($28M), CITIGROUP INC ($18.3M). Net institutional sentiment: Mixed.
111
Holders
Avg rating(27 Elite)
$307.1M
Total Value
62% (126)
Fund Consensus
73 buying - 45 selling
Who's Trading
InsiderWMWilson MartinSell $12KMay 13, 2026
InsiderCSChaudhuri SarbaniSell $68KMay 7, 2026
InsiderSGShah GauravSell $20KFeb 18, 2026
InsiderWMWilson MartinSell $5KFeb 18, 2026
InsiderMJMilitello JohnSell $4KFeb 18, 2026
InsiderSGShah GauravSell $41KFeb 13, 2026
InsiderWMWilson MartinSell $41KFeb 13, 2026
InsiderMJMilitello JohnSell $12KFeb 13, 2026
13F: Insider & Congress:
Showing 1-20 of 126
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer